You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / GLENMARK PHARMACEUTICALS LTD

GLENMARK PHARMACEUTICALS LTD Analysis

Returns | 1W : -2.6% , 1M : -1%,1Y : 41.2%
BOM : 532296     NSE : GLENMARK    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Jan 25,2021
Price(EOD): Rs. 491.30
This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.
MarketCap: Rs. 13,864.49 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
GLENMARK PHARMACEUTICALS LTD -2.6% -1% 41.2%
SUN PHARMACEUTICAL INDUSTRIES LTD -1.6% -0.6% 27.8%
DR REDDYS LABORATORIES LTD -0.1% -2.3% 65.7%
DIVIS LABORATORIES LTD -0.9% -4.8% 86.8%
CIPLA LTD 1.8% 0.4% 73.9%
BIOCON LTD -15.3% -20.6% 33.9%
AUROBINDO PHARMA LTD 8% 9.8% 88.7%
LUPIN LTD -0.8% 10.8% 46.3%
TORRENT PHARMACEUTICALS LTD -4.2% -5.3% 33.1%

FUNDAMENTAL ANALYSIS OF GLENMARK PHARMACEUTICALS LTD

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than GLENMARK PHARMACEUTICALS LTDPremium

As on 25-Jan-2021, the Fundamentals of GLENMARK PHARMACEUTICALS LTD are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of GLENMARK PHARMACEUTICALS LTD. Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!


VALUATION OF GLENMARK PHARMACEUTICALS LTD

 
Valuation Score
RatioValue
P/E
P/B
P/S
17.87
P/E Calculated based on EPS of 27.5
[ Mar2020 - Consolidated Results ]

2.29
P/B Calculated based on Book Value of 214.65
[ Mar2020 - Consolidated Results ]

1.3
P/S Calculated based on Revenues of 10662.9 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than GLENMARK PHARMACEUTICALS LTDPremium

As on 25-Jan-2021, GLENMARK PHARMACEUTICALS LTD is Under Valued and hence a good buying opportunity according to Share Valuation at this time!


INTRINSIC VALUE OF GLENMARK PHARMACEUTICALS LTD

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-32%
-55%
-51%

As on 25-Jan-2021, the Intrinsic Value of GLENMARK PHARMACEUTICALS LTD is Rs. 999.41 determined based on Median of the 3 historical models.
Fair Value based on Median EV / EBIDTA Model : Rs. 726.82
Fair Value based on Median EV / Sales Model : Rs. 1,102.15
Fair Value based on Median Price / Sales Model : Rs. 999.41
Median Fair Value of GLENMARK PHARMACEUTICALS LTD : Rs. 999.41

As on 25-Jan-2021, GLENMARK PHARMACEUTICALS LTD is trading at a Discount of -51% based on the Median Intrinsic Value!


SHARE PRICE MOMENTUM OF GLENMARK PHARMACEUTICALS LTD

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.27
0.26
0.29
0.27
0.8
0.8
0.9
0.83
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
25.92%
-2.92%
-5.1%
-7.89%
4.88%
-1.94%
-2.28%
-8.43%
QtrlyTrend
-4
Latest Qtr: Sep2020




Open Demat Account & Start Investing
    Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z